19.37 USD
-1.3 (-6.29%)
19.74 USD
+0.37 (+1.91%)
We assign a fundamental rating of 4 out of 10 to SMLR. SMLR was compared to 185 industry peers in the Health Care Equipment & Supplies industry. SMLR has a medium profitability rating, but doesn't score so well on its financial health evaluation. SMLR is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SMLR was profitable.
SMLR had a negative operating cash flow in the past year.
In the past 5 years SMLR has always been profitable.
SMLR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.10%, SMLR belongs to the top of the industry, outperforming 89.19% of the companies in the same industry.
The Return On Equity of SMLR (10.51%) is better than 87.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.1% | ||
| ROE | 10.51% | ||
| ROIC | N/A |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of SMLR (130.80%) is better than 99.46% of its industry peers.
In the last couple of years the Profit Margin of SMLR has grown nicely.
SMLR's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 90.83%, SMLR belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
SMLR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 130.8% | ||
| GM | 90.83% |
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
SMLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
SMLR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SMLR has been increased compared to 5 years ago.
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of 1.74, we must say that SMLR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.74, SMLR is in line with its industry, outperforming 55.68% of the companies in the same industry.
SMLR has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
SMLR has a Debt to Equity ratio (0.25) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.74 |
ROIC/WACCN/A
WACC9.81%
2.3 Liquidity
A Current Ratio of 1.97 indicates that SMLR should not have too much problems paying its short term obligations.
With a Current ratio value of 1.97, SMLR is not doing good in the industry: 61.08% of the companies in the same industry are doing better.
A Quick Ratio of 1.95 indicates that SMLR should not have too much problems paying its short term obligations.
The Quick ratio of SMLR (1.95) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.97 | ||
| Quick Ratio | 1.95 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 220.88% over the past year.
The Earnings Per Share has been growing by 24.17% on average over the past years. This is a very strong growth
SMLR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.30%.
The Revenue has been growing by 11.43% on average over the past years. This is quite good.
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
Revenue 1Y (TTM)-37.3%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%
3.2 Future
Based on estimates for the next years, SMLR will show a very negative growth in Earnings Per Share. The EPS will decrease by -29.01% on average per year.
SMLR is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -16.29% yearly.
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue Next Year-43.2%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 2.21 indicates a rather cheap valuation of SMLR.
SMLR's Price/Earnings ratio is rather cheap when compared to the industry. SMLR is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.19, SMLR is valued rather cheaply.
The Price/Forward Earnings ratio is 237.38, which means the current valuation is very expensive for SMLR.
Based on the Price/Forward Earnings ratio, SMLR is valued a bit cheaper than 65.41% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.88. SMLR is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.21 | ||
| Fwd PE | 237.38 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The decent profitability rating of SMLR may justify a higher PE ratio.
A cheap valuation may be justified as SMLR's earnings are expected to decrease with -29.01% in the coming years.
PEG (NY)N/A
PEG (5Y)0.09
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
5. Dividend
5.1 Amount
No dividends for SMLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
19.37
-1.3 (-6.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners65.81%
Inst Owner Change0%
Ins Owners4.75%
Ins Owner Change0%
Market Cap293.65M
Revenue(TTM)36.96M
Net Income(TTM)48.34M
Analysts82.22
Price Target66.98 (245.79%)
Short Float %20.65%
Short Ratio4.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1964.05%
Min EPS beat(2)1930.07%
Max EPS beat(2)1998.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.59%
Min Revenue beat(2)-6.63%
Max Revenue beat(2)-0.56%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.83%
PT rev (3m)-12.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)118.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.21 | ||
| Fwd PE | 237.38 | ||
| P/S | 7.95 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.64 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)8.76
EY45.22%
EPS(NY)0.08
Fwd EY0.42%
FCF(TTM)-1.79
FCFYN/A
OCF(TTM)-1.78
OCFYN/A
SpS2.44
BVpS30.33
TBVpS-5.28
PEG (NY)N/A
PEG (5Y)0.09
Graham Number77.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.1% | ||
| ROE | 10.51% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 130.8% | ||
| GM | 90.83% | ||
| FCFM | N/A |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score2
Asset Turnover0.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 55.77% | ||
| Cap/Sales | 0.63% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.97 | ||
| Quick Ratio | 1.95 | ||
| Altman-Z | 1.74 |
F-Score2
WACC9.81%
ROIC/WACCN/A
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-37.3%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%
Revenue Next Year-43.2%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
EBIT growth 1Y-126.25%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year-354.87%
EBIT Next 3Y-51.48%
EBIT Next 5YN/A
FCF growth 1Y-262.46%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y-244.7%
OCF growth 3Y14.98%
OCF growth 5Y13.91%
SEMLER SCIENTIFIC INC / SMLR FAQ
What is the ChartMill fundamental rating of SEMLER SCIENTIFIC INC (SMLR) stock?
ChartMill assigns a fundamental rating of 4 / 10 to SMLR.
Can you provide the valuation status for SEMLER SCIENTIFIC INC?
ChartMill assigns a valuation rating of 4 / 10 to SEMLER SCIENTIFIC INC (SMLR). This can be considered as Fairly Valued.
How profitable is SEMLER SCIENTIFIC INC (SMLR) stock?
SEMLER SCIENTIFIC INC (SMLR) has a profitability rating of 6 / 10.
What is the financial health of SEMLER SCIENTIFIC INC (SMLR) stock?
The financial health rating of SEMLER SCIENTIFIC INC (SMLR) is 3 / 10.